HIGH-DOSE RITUXIMAB IN THE CONDITIONING REGIMEN BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS IS ASSOCIATED WITH REDUCED GVHD-RELATED DEATHS, BUT DID NOT IMPROVE DISEASE CONTROL

被引：0
|
作者：
Dodero, A. [1 ]
Spina, F. [1 ]
Sarina, B. [2 ]
Carniti, C. [1 ]
Patriarca, F. [3 ]
Carella, A. M. [4 ]
Levis, A. [5 ]
Bosi, A. [6 ]
Falda, M. [7 ]
Di Raimondo, F. [8 ]
Di Bartolomeo, P. [9 ]
Dalto, S. [1 ]
Bacigalupo, A. [10 ]
Rambaldi, A. [11 ]
Corradini, P. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Ematol, Milan, Italy
[2] Humanitas Canc Ctr, Ematol, Rozzano, Italy
[3] Univ Udine, I-33100 Udine, Italy
[4] IRCCS Casa Solievo della Sofferenza, San Giovanni Rotondo, Italy
[5] Osped Alessandria, Ematol, Alessandria, Italy
[6] Azienda Osped Univ Carreggi, Ematol, Florence, Italy
[7] Osped San Giovanni Battista Torino, Ematol, Turin, Italy
[8] Osepedale Ferrarotto, Ematol, Catania, Italy
[9] Osped Pescara, Ematol, Pescara, Italy
[10] Osped San Martino Genova, Ematol, Genoa, Italy
[11] Osped Papa Giovanni XXIII, Ematol, Bergamo, Italy
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P393
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [21] High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
    Gladstone, Douglas E.
    Bolanos-Meade, Javier
    Huff, Carol Ann
    Zahurak, Marianna
    Flinn, Ian
    Borrello, Ivan
    Luznik, Leo
    Fuchs, Ephraim
    Kasamon, Yvette
    Matsui, William
    Powell, Jonathan
    Levitsky, Hyam
    Brodsky, Robert A.
    Ambinder, Richard
    Jones, Richard J.
    Swinnen, Lode J.
    LEUKEMIA & LYMPHOMA, 2011, 52 (11) : 2076 - 2081
  • [22] Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy
    El Gnaoui, T.
    Dupuis, J.
    Belhadj, K.
    Jais, J.-P.
    Rahmouni, A.
    Copie-Bergman, C.
    Gaillard, I.
    Divine, M.
    Tabah-Fisch, I.
    Reyes, F.
    Haioun, C.
    ANNALS OF ONCOLOGY, 2007, 18 (08) : 1363 - 1368
  • [23] A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results
    Srour, Samer A.
    Li, Shaoying
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Lozano-Cerrada, Sara
    Maadani, Farzeneh
    Alousi, Amin
    Kebriaei, Partow
    Anderlini, Paolo
    Nieto, Yago
    Jones, Roy
    Shpall, Elizabeth
    Champlin, Richard E.
    Hosing, Chitra
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (04) : 561 - 570
  • [24] Reduced-intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in neuroblastoma either refractory or relapsed after autologous stem cell transplantation
    Prete, A.
    Rondelli, R.
    Lanino, E.
    Pession, A.
    Locatelli, F.
    Zecca, M.
    Messina, C.
    Caselli, D.
    Favre, C.
    Rabusin, M.
    Fagioli, F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S88 - S88
  • [25] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [26] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    T Aoki
    K Shimada
    R Suzuki
    K Izutsu
    A Tomita
    Y Maeda
    J Takizawa
    K Mitani
    T Igarashi
    K Sakai
    K Miyazaki
    K Mihara
    K Ohmachi
    N Nakamura
    H Takasaki
    H Kiyoi
    S Nakamura
    T Kinoshita
    M Ogura
    Blood Cancer Journal, 2015, 5 : e372 - e372
  • [27] Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
    Fan Yang
    Hui Shi
    Teng Xu
    Rui Liu
    Yang Lei
    Ruiting Li
    Biping Deng
    Tong Wu
    Xiaoyan Ke
    Kai Hu
    Bone Marrow Transplantation, 2023, 58 : 440 - 442
  • [28] Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
    Yang, Fan
    Shi, Hui
    Xu, Teng
    Liu, Rui
    Lei, Yang
    Li, Ruiting
    Deng, Biping
    Wu, Tong
    Ke, Xiaoyan
    Hu, Kai
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 440 - 442
  • [29] Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias
    G Massenkeil
    M Nagy
    S Neuburger
    I Tamm
    C Lutz
    P le Coutre
    O Rosen
    K-D Wernecke
    B Dörken
    R Arnold
    Bone Marrow Transplantation, 2005, 36 : 683 - 689
  • [30] Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias
    Massenkeil, G
    Nagy, M
    Neuburger, S
    Tamm, I
    Lutz, C
    le Coutre, P
    Rosen, O
    Wernecke, KD
    Dörken, B
    Arnold, R
    BONE MARROW TRANSPLANTATION, 2005, 36 (08) : 683 - 689
12345